Opendata, web and dolomites

LeukemiaEnviron SIGNED


Total Cost €


EC-Contrib. €






 LeukemiaEnviron project word cloud

Explore the words cloud of the LeukemiaEnviron project. It provides you a very rough idea of what is the project "LeukemiaEnviron" about.

mediated    samples    disease    microenvironment    universal    propensity    times    therapeutically    immune    obtain    first    biology    print    cll    lymphocytic    course    re    lymph    malignant    stream    cd20    inhibited    data    interactions    cell    pdx    signalling    therapeutic    microenvironments    transplantable    interaction    survival    see    utilized    il4    relevance    mirnas    signaling    mouse    regulation    inhibitors    function    vs    12    figure    pro    responsible    rituximab    constantly    microenvironmental    led    nfkb    therapies    mechanisms    integrate    finger    mir    leukemia    interleukin    model    transferable    normal    bcr    therapy    blood    proliferative    cells    nodes    peripheral    chronic    dependency    frequent    node    proliferation    unknown    influences    signals    niches    29    activation    hypothesize    regulator    cd40    adults    animal    circulate    stable    receptor    reveal    engraftment    malignancies    primary    acts    proteins    complicates    implication   

Project "LeukemiaEnviron" data sheet

The following table provides information about the project.

Masarykova univerzita 

Organization address
address: Zerotinovo namesti 9
postcode: 60177

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Czech Republic [CZ]
 Total cost 1˙499˙990 €
 EC max contribution 1˙499˙990 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2018-STG
 Funding Scheme ERC-STG
 Starting year 2019
 Duration (year-month-day) from 2019-06-01   to  2024-05-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    Masarykova univerzita CZ (BRNO STRED) coordinator 1˙499˙990.00


 Project objective

B cell chronic lymphocytic leukemia (CLL) is the most frequent leukemia in adults. CLL cells are characterized by their universal dependency on pro-survival and pro-proliferative signals from immune niches. To achieve this they constantly re-circulate between blood and lymph nodes, which is inhibited by novel microenvironment-targeting therapies such as “BCR inhibitors”. We aim to reveal how the malignant B cells change the propensity of their signalling pathways in response to the different microenvironments such as peripheral blood vs lymph node to obtain the proliferative signals. This is of major relevance for CLL, but also transferable to the biology of some other B cell malignancies and/or normal B cells. We analyzed the “finger print” of microenvironmental interactions in many CLL samples at various times during the disease course or during therapy. The obtained data led us to hypothesize on the mechanisms of regulation of signalling propensity of two pathways that are responsible for proliferation and survival of CLL cells, namely B Cell Receptor (BCR) signalling and signals from T-cells mediated by CD40/IL4. In aim 1 we hypothesize that CD20 is one of the key proteins involved in CLL cell activation, and influences BCR and interleukin signalling (see figure). This has important therapeutic implication since CD20 is used as a therapeutic target for 20 years (rituximab), but its function in CLL/normal B cells is unknown. In aim 2 we hypothesize that miR-29 acts a key regulator of T-cell signalling from CD40 and down-stream NFkB activation (see figure). This represents the first example of miRNAs‘ role in the propensity of T-cell interaction, and could be also utilized therapeutically. In aim 3 we will integrate our data on microenvironmental signaling (aim 12) and develop a first mouse model for PDX that would allow stable engraftment of primary CLL cells. Currently, CLL is non-transplantable to any animal model which complicates studies of its biology.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LEUKEMIAENVIRON" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LEUKEMIAENVIRON" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

NanoPD_P (2020)

High throughput multiplexed trace-analyte screening for diagnostics applications

Read More  


The Enemy of the Good: Towards a Theory of Moral Progress

Read More  

RTMFRM (2019)

Room Temperature Magnetic Resonance Force Microscopy

Read More